Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...
Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi and Canalevia-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1 ...
Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failureAssociated ...
In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.
President Trump is targeting a number of blue states amid the fraud scandal plaguing Minnesota, raising questions about the ...
US Attorney General Pam Bondi deleted a social media post after it became clear that the chart she shared to praise the Trump administration's handling of the opioid crisis actually showed a decline ...
According to O Jornal Económico, AIMA is among the public service entities that received the most complaints in 2025.
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
The autonomous regions of the Azores and Madeira recorded positive economic growth in 2024, but at a slower pace than in ...
Facing a deadline to appeal, the Justice Department told the courts late Thursday that it would try to overturn a judge’s ruling in favor of Harvard. By Alan Blinder The Trump administration said late ...
The proposal would have required recipients to get treatment for addiction or mental illness as a condition of receiving housing funds. The administration has said it will try again. By Jason DeParle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback